LIBTAYO: payments to doctors
Payments that named LIBTAYO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $27.2M
- Providers
- 25,948
- Transactions
- 119,374
- Average per transaction
- $228
The per-transaction average — $228 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 25,948 providers the average total is $1,049, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $17,573,359 | 64.5% |
| Sanofi | $5,218,201 | 19.2% |
| Regeneron | $4,254,077 | 15.6% |
| Sanofi-aventis U.S. LLC | $182,412 | 0.7% |